Oral Health Group

Nobel Biocare and DOCERAM Medical Ceramics Announce Expanded Partnership in Premium Restorative Solutions

November 3, 2020
by Nobel Biocare

Nobel Biocare and DOCERAM Medical Ceramics are combining their strengths to offer more high-quality restorative solutions, and with ease and flexibility for customers in mind.

Nobel Biocare is a worldwide pioneer in innovative implant-based treatment solutions, including the NobelProcera® service for individualized restorations. DOCERAM Medical Ceramics is an internationally recognized dental ceramics manufacturer with the Nacera brand. The first achievement in this strengthened partnership is the release of the NobelProcera® Zirconia Implant Bridge, which enables restorative flexibility through a simplified workflow and is produced with the high-end Nacera® Pearl zirconia material.

NobelProcera® next generation Zirconia implant bridge, from 2-14 units in various design options, including full contour. © Courtesy of Nobel Biocare

NobelProcera® next generation Zirconia implant bridge, from 2-14 units in various design options, including full contour. © Courtesy of Nobel Biocare

The two dental specialists have already been cooperating for many years in research, development and production. The crucial factor for both parties throughout has always been the exceptionally high standard of quality and reliability of the products as well as the associated customer satisfaction. Going forward, the aim is to further enhance this successful cooperation strategically.

The even closer cooperation between the two companies creates synergies for mutual advancement, including technical training and customer service.

Dr. Karl-Heinz Klotz, Business Unit Director at DOCERAM Medical Ceramics explains: “We are bringing the cooperation to a new level with the current agreement. This allows us to serve the implant sector through a strong partner with our Nacera products. Due to the extremely high level of expertise in implantology at Nobel Biocare, we can adapt our products exactly to the local dental requirements. A development from which the patient ultimately benefits.”

Natasha Haddad, Business Unit Head at NobelProcera® adds: “The comprehensive product know-how of DOCERAM Medical Ceramics supports us above all in the area of research and development and in user support. In this way, we can offer our customers first-class service and are ideally prepared for future challenges.”

For more than 20 years, DOCERAM Medical Ceramics GmbH has used its technical expertise to engage in the development and manufacture of zirconium oxide components for dental technology. The Nacera brand and Nacera Pearl series offer dental technicians a zirconium oxide material combining high bending strength and optimum aesthetics. High-quality Nacera process-optimization products, and other accessories for finalizing full monolithic restorations, are also supplied so that zircon processing can be completed in the laboratory.

About Nobel Biocare

Nobel Biocare is a world leader in the field of innovative implant-based dental restorations. The company’s portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems (including key brands NobelActive® and NobelParallel™ and ceramic implant NobelPearl™*) a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems (NobelProcera®), digital solutions for treatment planning and guided surgery (NobelClinician® and DTX Studio™ suite) as well as biomaterials. Nobel Biocare supports its customers through all phases of professional development, offering world-class training and education along with practice support and patient information materials. The company is headquartered in Zurich, Switzerland. Production takes place at four sites located in the United States, Sweden and Japan. Products and services are available in over 80 countries through subsidiaries and distributors.

*Distributed by Nobel Biocare. Manufactured by Dentalpoint AG

Print this page


Have your say:

Your email address will not be published.